Search Results - "ZALOUDEK, C"

Refine Results
  1. 1

    Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study by Scheidler, J, Hricak, H, Vigneron, D B, Yu, K K, Sokolov, D L, Huang, L R, Zaloudek, C J, Nelson, S J, Carroll, P R, Kurhanewicz, J

    Published in Radiology (01-11-1999)
    “…To assess the efficacy of combined magnetic resonance (MR) imaging and three-dimensional (3D) proton MR spectroscopic imaging in the detection and localization…”
    Get more information
    Journal Article
  2. 2

    Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging by Yu, K K, Scheidler, J, Hricak, H, Vigneron, D B, Zaloudek, C J, Males, R G, Nelson, S J, Carroll, P R, Kurhanewicz, J

    Published in Radiology (01-11-1999)
    “…To determine if the addition of three-dimensional (3D) proton magnetic resonance (MR) spectroscopic imaging to endorectal MR imaging helps diagnose…”
    Get more information
    Journal Article
  3. 3

    Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis by Yu, K K, Hricak, H, Alagappan, R, Chernoff, D M, Bacchetti, P, Zaloudek, C J

    Published in Radiology (01-03-1997)
    “…To determine which magnetic resonance (MR) imaging features are most predictive of extracapsular extension of prostate carcinoma. In 77 patients who had stage…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images by White, S, Hricak, H, Forstner, R, Kurhanewicz, J, Vigneron, D B, Zaloudek, C J, Weiss, J M, Narayan, P, Carroll, P R

    Published in Radiology (01-05-1995)
    “…To assess the frequency of changes in signal intensity after prostatic biopsy and the effect of these changes on the magnetic resonance (MR) imaging staging of…”
    Get more information
    Journal Article
  6. 6

    Vascular endothelial growth factor localization in human ovary and fallopian tubes : possible role in reproductive function and ovarian cyst formation by GORDON, J. D, MESIANO, S, ZALOUDEK, C. J, JAFFE, R. B

    “…Vascular endothelial growth factor (VEGF) is a potent angiogenic factor that also increases vascular permeability. We hypothesized that VEGF plays a role in…”
    Get full text
    Journal Article
  7. 7
  8. 8

    An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer by Suzuki, S, Moore, 2nd, D H, Ginzinger, D G, Godfrey, T E, Barclay, J, Powell, B, Pinkel, D, Zaloudek, C, Lu, K, Mills, G, Berchuck, A, Gray, J W

    Published in Cancer research (Chicago, Ill.) (01-10-2000)
    “…This report describes analyses of associations of genome copy number abnormalities in ovarian cancers with clinical features using genome-wide graphical and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Preoperative staging of cervical carcinoma: phased array coil fast spin- echo versus body coil spin-echo T2-weighted MR imaging by Yu, KK, Hricak, H, Subak, LL, Zaloudek, CJ, Powell, CB

    Published in American journal of roentgenology (1976) (01-09-1998)
    “…This study was performed to compare the diagnostic efficacy of MR imaging in the preoperative evaluation of invasive cervical cancer using the pelvic phased…”
    Get full text
    Journal Article
  11. 11

    Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA ) by HUANG, Mei-Chuan, LEE, Hsin-Yu, YEH, Che-Chung, KONG, Yvonne, ZALOUDEK, Charles J, GOETZL, Edward J

    Published in Oncogene (08-01-2004)
    “…The lipid growth factor lysophosphatidic acid (LPA) is produced by ovarian cancer cells in quantities sufficient to attain concentrations of up to 10 microM…”
    Get full text
    Journal Article
  12. 12

    Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value by Costa, M J, DeRose, P B, Roth, L M, Brescia, R J, Zaloudek, C J, Cohen, C

    Published in Human pathology (01-01-1994)
    “…Granulosa cell tumors (GCTs) represent 1.5% to 3% of primary and 6% to 10% of malignant ovarian neoplasms, and present little diagnostic difficulty in the…”
    Get more information
    Journal Article
  13. 13

    A decline in myometrial nitric oxide synthase expression is associated with labor and delivery by Bansal, R K, Goldsmith, P C, He, Y, Zaloudek, C J, Ecker, J L, Riemer, R K

    Published in The Journal of clinical investigation (15-05-1997)
    “…The mechanisms that maintain relative uterine quiescence during pregnancy remain largely unknown. A possible role for nitric oxide has recently emerged,…”
    Get full text
    Journal Article
  14. 14

    Bacillary angiomatosis of the cervix and vulva in a patient with aids by Long, Steven R., Whitfeld, Margot J., Eades, Carol, Koehler, Jane E., Korn, Abner P., Zaloudek, Charles J.

    Published in Obstetrics and gynecology (New York. 1953) (01-10-1996)
    “…Bacillary angiomatosis is a clinicopathologic entity that most often is identified in the skin of patients with AIDS. This report presents an example of…”
    Get full text
    Journal Article
  15. 15

    Importance of atypical glandular cells of uncertain significance in cervical cytologic smears by KORN, A. P, JUDSON, P. L, ZALOUDEK, C. J

    Published in Journal of reproductive medicine (01-09-1998)
    “…To determine the clinical implications of atypical glandular cells of uncertain significance (AGCUS) in cervical cytologic smears. Retrospective analysis…”
    Get full text
    Journal Article
  16. 16

    Microglandular adenocarcinoma of the endometrium: a form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix by Zaloudek, C, Hayashi, G M, Ryan, I P, Powell, C B, Miller, T R

    “…Microglandular adenocarcinoma of the endometrium may cause diagnostic problems because of its bland cytologic appearance and its histologic similarity to…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Adenofibroma and adenosarcoma of the uterus: a clinicopathologic study of 35 cases by Zaloudek, C J, Norris, H J

    Published in Cancer (15-07-1981)
    “…The clinical and histopathologic features of ten adenofibromas and 25 adenosarcomas of the uterus were studied. The most useful criterion for distinguishing…”
    Get more information
    Journal Article
  19. 19

    Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy by Powell, C Bethan, Kenley, Eric, Chen, Lee-May, Crawford, Beth, McLennan, Jane, Zaloudek, Charles, Komaromy, Miriam, Beattie, Mary, Ziegler, John

    Published in Journal of clinical oncology (01-01-2005)
    “…Women who carry deleterious mutations of BRCA1 or BRCA2 genes have up to a 54% lifetime risk of developing ovarian cancer. After childbearing, women at high…”
    Get full text
    Journal Article
  20. 20

    Desmoplastic small cell tumor of the ovary: a unique polyphenotypic tumor with an unfavorable prognosis by Zaloudek, C, Miller, T R, Stern, J L

    “…Desmoplastic small cell tumor (DSCT) is a recently described intraabdominal neoplasm of uncertain histogenesis that occurs predominantly in boys and young men…”
    Get more information
    Journal Article